Back to series
Efficacy and Safety of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri

Efficacy and Safety of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Ahmad Masri
Expected completion time: 15 mins
0.25 CPD Credit

Late Breaking Clinical Trial - Presented at #ESC HF 2022

Sign up to start learning
,